Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Irritable Bowel Syndrome
NCT06437041 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2024-05-31
Summary
This is a randomized controlled trial to explore the efficacy of antibiotic pretreatment on the efficacy of WMT in the treatment of Irritable bowel syndrome in adults: a multi-center, randomized, placebo-controlled clinical study
Conditions
- Irritable Bowel Syndrome
Interventions
- DRUG
-
Ornidazole
Patients will receive three consecutive enemas of ornidazole 0.5g+50ml saline through the TET tube, followed by WMT treatment once daily for a duration of 3 days.
- DRUG
-
Patients will receive three consecutive enemas of placebo of equal volume through the TET tube, followed by WMT treatment once daily for a duration of 3 days
Sponsors & Collaborators
-
Faming Zhang
lead OTHER
Principal Investigators
-
Faming Zhang, PhD · The Second Hospital of Nanjing Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2029-12-31
- Completion
- 2030-03-31
Countries
- China
Study Locations
More Related Trials
-
Probiotics in Irritable Bowel Syndrome
NCT00846170 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
NCT01893606 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluate the Effect of Synbiotics in Irritable Bowel Syndrome
NCT06647043 ·Status: RECRUITING ·Phase: NA
-
A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
NCT00399438 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
NCT05923892 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT04129619 ·Status: COMPLETED ·Phase: PHASE2
-
A Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS)
NCT06636513 ·Status: RECRUITING ·Phase: NA
-
A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome
NCT03721107 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
NCT00139672 ·Status: COMPLETED ·Phase: PHASE2
-
Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial
NCT07061184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome
NCT00786123 ·Status: COMPLETED ·Phase: NA
-
Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome
NCT04662957 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT02788071 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study of Probiotics in Adults With Irritable Bowel Syndrome
NCT00971711 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
NCT06247046 ·Status: RECRUITING ·Phase: PHASE3
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02107196 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
NCT01629212 ·Status: UNKNOWN ·Phase: PHASE4
-
Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome
NCT02092402 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.
NCT04890405 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)
NCT06201182 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
NCT05719896 ·Status: UNKNOWN ·Phase: PHASE2